## Gilead Sciences Inc. | Healthcare Biotechnology |

68.25 | 3 | 4.60% | 88.8 | 60.54 |

52 Week Low |

Financial Ratios

Earnings per Share (EPS) | 1.21 |

EPS Estimate Currrent Qtr | 1.63 |

Book Value Per Share | 17.67 |

Market Cap | 88 Billion |

PE Ratio | 51.4 |

Dividend Yield | 3.6064537 |

Stock Yield

Stock Return 7 Days | 2.21% |

Stock Return 15 Days | -4.98% |

Stock Return 30 Days | -12.67% |

Stock Return 3 Months | -21.34% |

Stock Return One Year | -15.89% |

Stock Return 3 Years | -14.98% |

Stock Technical Analysis

Relative Strengh Index (14) | 40.49 |

Average True Range (14) | 2.49 |

Momentum (14) | -2.89 |

Simple Moving Average (14) | -2.89 |

Time Series Forecast (14) | 60.7 |

Time Series Forecast (30) | 70.26 |

Stock News

Financial Statements

index | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|

Revenue | 25 Billion | 33 Billion | 30 Billion | 26 Billion |

Cost of Revenue | 4 Billion | 4 Billion | 4 Billion | 4 Billion |

Gross Profit | 21 Billion | 29 Billion | 26 Billion | 22 Billion |

Gross Margin (%) | 84.78% | 87.73% | 85.98% | 83.26% |

Selling General and Administrative Expense | 3 Billion | 3 Billion | 3 Billion | 4 Billion |

Other operating expenses | 3 Billion | 3 Billion | 5 Billion | 3 Billion |

Earning Before Interest and Taxes EBIT | 15 Billion | 22 Billion | 18 Billion | 15 Billion |

EBIT/Operating Margin (%) | 61.51% | 68.47% | 59.47% | 56.04% |

Interest Expense | 412 Million | 688 Million | 964 Million | 1 Billion |

Other non-operating expenses/income | 0 | 0 | 0 | 0 |

Earnings before Tax | 15 Billion | 22 Billion | 17 Billion | 14 Billion |

Income Tax Expense | 3 Billion | 4 Billion | 4 Billion | 9 Billion |

Net Income | 12 Billion | 18 Billion | 14 Billion | 5 Billion |

Net Margin (%) | 48.62% | 55.48% | 44.43% | 17.73% |

Earnings per share from operating income | 0.172134 | 0.103628 | 0.13468 | 0.900686 |

Earnings per Diluted Share | 7.35 | 11.91 | 9.94 | 3.51 |

Dividends per Basic Common Share | 0 | 1.29 | 1.84 | 2.08 |

Payout ratio | NA | 9.23256 | 5.40217 | 1.6875 |

Weighted average number of shares outstanding | 2 Billion | 2 Billion | 1 Billion | 1 Billion |

index | 2017 Q4 | 2018 Q1 | 2018 Q2 | 2018 Q3 |
---|---|---|---|---|

Revenue | 6 Billion | 5 Billion | 6 Billion | 6 Billion |

Cost of Revenue | 1 Billion | 1 Billion | 1 Billion | 1 Billion |

Gross Profit | 5 Billion | 4 Billion | 4 Billion | 5 Billion |

Gross Margin (%) | 78.89% | 80.33% | 78.82% | 80.59% |

Selling General and Administrative Expense | 1 Billion | 997 Million | 980 Million | 948 Million |

Other operating expenses | 1 Billion | 768 Million | 1 Billion | 636 Million |

Earning Before Interest and Taxes EBIT | 2 Billion | 2 Billion | 2 Billion | 3 Billion |

EBIT/Operating Margin (%) | 40.24% | 45.64% | 41.61% | 52.29% |

Interest Expense | 297 Million | 290 Million | 266 Million | 264 Million |

Other non-operating expenses/income | 0 | 0 | 0 | 0 |

Earnings before Tax | 2 Billion | 2 Billion | 2 Billion | 3 Billion |

Income Tax Expense | 6 Billion | 494 Million | 267 Million | 565 Million |

Net Income | -4 Billion | 2 Billion | 2 Billion | 2 Billion |

Net Margin (%) | -100.00% | 30.23% | 32.17% | 37.47% |

Earnings per share from operating income | 0.211401 | 1.29039 | 0.930461 | 0.872079 |

Earnings per Diluted Share | -3 | 1.17 | 1.39 | 1.6 |

Dividends per Basic Common Share | 0.52 | 0.57 | 0.57 | 0.57 |

Payout ratio | -6 | 2.05263 | 2.4386 | 2.80702 |

Weighted average number of shares outstanding | 1 Billion | 1 Billion | 1 Billion | 1 Billion |

index | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|

Cash and Equivalents | 10 Billion | 13 Billion | 8 Billion | 8 Billion |

Trade and Non Trade Receivables | 5 Billion | 6 Billion | 5 Billion | 4 Billion |

Inventory | 1 Billion | 2 Billion | 2 Billion | 801 Million |

Other current assets | 22 Billion | 30 Billion | 22 Billion | 35 Billion |

Current Assets | 18 Billion | 25 Billion | 20 Billion | 32 Billion |

Total Non-Current Assets | 17 Billion | 27 Billion | 37 Billion | 38 Billion |

Total Assets | 35 Billion | 52 Billion | 57 Billion | 70 Billion |

Trade and Non Trade Payables | 955 Million | 1 Billion | 1 Billion | 814 Million |

Other current liabilities | 5 Billion | 9 Billion | 8 Billion | 11 Billion |

Current Liabilities | 6 Billion | 10 Billion | 9 Billion | 12 Billion |

Liabilities Non Current | 13 Billion | 23 Billion | 28 Billion | 38 Billion |

Accumulated Retained Earnings Deficit | 13 Billion | 18 Billion | 18 Billion | 19 Billion |

Shareholder’s equity other | 3 Billion | 533 Million | 733 Million | 1 Billion |

Shareholders Equity | 15 Billion | 19 Billion | 19 Billion | 20 Billion |

Noncontrolling interests | 12 Billion | 20 Billion | 19 Billion | 23 Billion |

Total Assets | 35 Billion | 52 Billion | 57 Billion | 70 Billion |

index | 2017 Q4 | 2018 Q1 | 2018 Q2 | 2018 Q3 |
---|---|---|---|---|

Cash and Equivalents | 8 Billion | 8 Billion | 13 Billion | 15 Billion |

Trade and Non Trade Receivables | 4 Billion | 4 Billion | 4 Billion | 3 Billion |

Inventory | 801 Million | 885 Million | 859 Million | 816 Million |

Other current assets | 35 Billion | 33 Billion | 42 Billion | 45 Billion |

Current Assets | 32 Billion | 30 Billion | 33 Billion | 35 Billion |

Total Non-Current Assets | 38 Billion | 35 Billion | 33 Billion | 29 Billion |

Total Assets | 70 Billion | 65 Billion | 65 Billion | 64 Billion |

Trade and Non Trade Payables | 814 Million | 711 Million | 623 Million | 580 Million |

Other current liabilities | 11 Billion | 10 Billion | 10 Billion | 10 Billion |

Current Liabilities | 12 Billion | 11 Billion | 11 Billion | 10 Billion |

Liabilities Non Current | 38 Billion | 34 Billion | 33 Billion | 31 Billion |

Accumulated Retained Earnings Deficit | 19 Billion | 19 Billion | 20 Billion | 21 Billion |

Shareholder’s equity other | 1 Billion | 1 Billion | 2 Billion | 2 Billion |

Shareholders Equity | 20 Billion | 21 Billion | 22 Billion | 23 Billion |

Noncontrolling interests | 23 Billion | 21 Billion | 22 Billion | 20 Billion |

Total Assets | 70 Billion | 65 Billion | 65 Billion | 64 Billion |

index | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|

Net Cash Flow from Operations | 13 Billion | 21 Billion | 17 Billion | 12 Billion |

Capital Expenditure | -557 Million | -747 Million | -748 Million | -590 Million |

Net Cash Flow from Investing | -2 Billion | -12 Billion | -12 Billion | -16 Billion |

Net Cash Flow from Financing | -3 Billion | -6 Billion | -10 Billion | 3 Billion |

Cash and Equivalents | 10 Billion | 13 Billion | 8 Billion | 8 Billion |

index | 2017 Q4 | 2018 Q1 | 2018 Q2 | 2018 Q3 |
---|---|---|---|---|

Net Cash Flow from Operations | 3 Billion | 2 Billion | 2 Billion | 2 Billion |

Capital Expenditure | -220 Million | -212 Million | -297 Million | -167 Million |

Net Cash Flow from Investing | -10 Billion | 4 Billion | 5 Billion | 2 Billion |

Net Cash Flow from Financing | 3 Billion | -7 Billion | -1 Billion | -3 Billion |

Cash and Equivalents | 8 Billion | 8 Billion | 13 Billion | 15 Billion |